Format

Send to

Choose Destination
Polymers (Basel). 2019 Jan 18;11(1). pii: E174. doi: 10.3390/polym11010174.

Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification.

Author information

1
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. antonova.la@mail.ru.
2
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. silnik@niboch.nsc.ru.
3
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. sevostv@gmail.com.
4
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. yuzhalin@gmail.com.
5
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. koroleva@niboch.nsc.ru.
6
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. veliea@cardio.kem.ru.
7
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. a.mir.80@mail.ru.
8
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. godov@niboch.nsc.ru.
9
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. antonkutikhin@gmail.com.
10
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. bio.tvg@mail.ru.
11
Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. inna_serpokrylova@biosset.com.
12
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. sergeewa.ew@yandex.ru.
13
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. matveeva_vg@mail.ru.
14
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. Khanovam@gmail.com.
15
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. t.akentyeva@mail.ru.
16
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. leonora92@mail.ru.
17
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. jackie1970@mail.ru.
18
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia. reception@kemcardio.ru.

Abstract

Modification with Arg-Gly-Asp (RGD) peptides is a promising approach to improve biocompatibility of small-calibre vascular grafts but it is unknown how different RGD sequence composition impacts graft performance. Here we manufactured 1.5 mm poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(ε-caprolactone) grafts modified by distinct linear or cyclic RGD peptides immobilized by short or long amine linker arms. Modified vascular prostheses were tested in vitro to assess their mechanical properties, hemocompatibility, thrombogenicity and endothelialisation. We also implanted these grafts into rat abdominal aortas with the following histological examination at 1 and 3 months to evaluate their primary patency, cellular composition and detect possible calcification. Our results demonstrated that all modes of RGD modification reduce ultimate tensile strength of the grafts. Modification of prostheses does not cause haemolysis upon the contact with modified grafts, yet all the RGD-treated grafts display a tendency to promote platelet aggregation in comparison with unmodified counterparts. In vivo findings identify that cyclic Arg-Gly-Asp-Phe-Lys peptide in combination with trioxa-1,13-tridecanediamine linker group substantially improve graft biocompatibility. To conclude, here we for the first time compared synthetic small-diameter vascular prostheses with different modes of RGD modification. We suggest our graft modification regimen as enhancing graft performance and thus recommend it for future use in tissue engineering.

KEYWORDS:

RGD peptides; arterial replacement; endothelialisation; tissue engineering; vascular grafts

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center